Bogenberger, J M <br/><br/>
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies.  [electronic resource] 

 -  Leukemia  Aug 2014 
 - 1657-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2014.44  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--pharmacology<br/>Azacitidine--pharmacology<br/>Biphenyl Compounds--pharmacology<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Cell Line, Tumor<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Myelodysplastic Syndromes--drug therapy<br/>Myeloid Cell Leukemia Sequence 1 Protein--antagonists & inhibitors<br/>Myeloproliferative Disorders--drug therapy<br/>Nitrophenols--pharmacology<br/>Piperazines--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>RNA Interference<br/>Sulfonamides--pharmacology<br/>bcl-X Protein--antagonists & inhibitors